Amrutanjan Health Care Limited

rs,

r / Madam, November 14, 2023 BSE Limited Department of Corporate Services 1* Floor, P.J. Towers, Dalal Street, Mumbai 400 001 Scrip Code: 590006 Sub: Investor Presentation for the Quarter and

2845 crore

ad Category Body Category Congestion Category • The Body category in MAT Sept’23* is valued at 2845 crores with a value growth of 5.8% and a volume growth of 0.8%. In a highly fragmented and competitive

5.8%

tion Category • The Body category in MAT Sept’23* is valued at 2845 crores with a value growth of 5.8% and a volume growth of 0.8%. In a highly fragmented and competitive category, Amrutanjan register

0.8%

egory in MAT Sept’23* is valued at 2845 crores with a value growth of 5.8% and a volume growth of 0.8%. In a highly fragmented and competitive category, Amrutanjan registered a value growth of 14.4% a

14.4%

of 0.8%. In a highly fragmented and competitive category, Amrutanjan registered a value growth of 14.4% and a volume growth of 13.4% in MAT Sep’23. • Refreshed packaging designs complete congestion c

13.4%

d and competitive category, Amrutanjan registered a value growth of 14.4% and a volume growth of 13.4% in MAT Sep’23. • Refreshed packaging designs complete congestion care range. across the • L

Rs 30

2 new products in H1: • Relief Cough and Cold Hot Drink, addressing sore throat. • Relief Mint Rs 30 pouches addressing lower town classes. • The Head category in MAT Sept’23* is at 1637 crores. T

1637 crore

ief Mint Rs 30 pouches addressing lower town classes. • The Head category in MAT Sept’23* is at 1637 crores. The value growth of 3.0% is ahead of volume growth which is at -1.8% and that is largely on acc

3.0%

lower town classes. • The Head category in MAT Sept’23* is at 1637 crores. The value growth of 3.0% is ahead of volume growth which is at -1.8% and that is largely on account of price increase. In

1.8%

n MAT Sept’23* is at 1637 crores. The value growth of 3.0% is ahead of volume growth which is at -1.8% and that is largely on account of price increase. In Jul- Sep’23* period Amrutanjan is the only br

2.7%

ncrease. In Jul- Sep’23* period Amrutanjan is the only brand to have registered a volume growth of 2.7% ahead of category's volume growth of 2.0%. • As per internal sales, larger SKU’s of Amrutanjan P

2.0%

is the only brand to have registered a volume growth of 2.7% ahead of category's volume growth of 2.0%. • As per internal sales, larger SKU’s of Amrutanjan Pain Balm Extra Power (Yellow Balm) 27.5ml a

“Investor Presentation | Quarter and Half Year Ended 30th September 2023 19 Management Commentary Investor Presentation | Quarter and Half Year Ended 30th September 2023 20 Management Commentary • We had to defer revenue of 9.7 crs to the next quarter owing to supply chain issues.”

Notes

2

SAP Project

1

SAP Project

We have implemented the below during this period April to Sep’23 • Material Requirement Planning (MRP) • • Automatic Payment run & Automatic RTGS collection posting by integrating the Bank portal with SAP. Customer credit limits are fixed in SAP. Investor Presentation | Quarter and Half Year Ended 30th September 2023 12 Financials Investor Presentation | Quarter and Half Year Ended 30th September 2023 13 Financials – Q2 FY24 (Rs. in Crores) Net Sales 110.72 99.31 Profit Before Tax 17.42 Profit After Tax 12.77 9.21 6.85 Q2 FY24 Q2 FY23 Q2 FY24 Q2 FY23 Q2 FY24 Q2 FY23 Investor Presentation | Quarter and Half Year Ended 30th September 2023 14 Financials – Q2 FY24 (Rs. in Crores) Net Sales - OTC 94.08 104.23 Net Sales - Beverages 6.00 4.84 Q2 FY24 Q2 FY23 Q2 FY24 Q2 FY23 Net Sales - Comfy 26.37 24.27 Q2 FY24 Q2 FY23 Growth: 8.65% Net Sales - Electro Plus 4.97 3.25 Q2 FY24 Q2 FY23 Investor Presentation | Quarter and Half Year Ended 30th September 2023 15 Financials – H1 FY24 (Rs. in Crores)

Notes

H1 FY24 H1 FY23 Net Sales - Comfy 46.97 41.13 H1 FY24 H1 FY23 Growth: 14.20% • Majority of raw material prices are lower than H1 FY23. Menthol price is marginally higher than H1 FY23. • Majority of packing material prices are lower than H1 FY23. • Advertisement spend for H1 FY24 is at Rs.12.97 cr against Rs.13.56 cr for H1 FY23. Advertisement spend for Comfy is at Rs. 3.08 cr for H1 FY24 against Rs. 7.72 cr for H1 FY23. Investor Presentation | Quarter and Half Year Ended 30th September 2023 18 Financials – H1 FY24 – Beverage Division (Rs. in Crores) Net Sales - Beverages 16.13 13.97 H1 FY24 H1 FY23 Growth: 15.46% Net Sales - Electro Plus 11.23 10.91 H1 FY24 H1 FY23 Growth: 2.93%

Notes

• Majority of Raw Material prices are marginally higher when compared to H1 FY23. • Major Packing Material prices are lower when compared to H1 FY23. • Advertisement spend is at Rs. 2.46 cr for H1 FY24 against Rs. 3.10 cr for H1 FY23. • Business is continuing with cash & carry model for Fruitnik. Investor Presentation | Quarter and Half Year Ended 30th September 2023 19 Management Commentary Investor Presentation | Quarter and Half Year Ended 30th September 2023 20 Management Commentary • We had to defer revenue of 9.7 crs to the next quarter owing to supply chain issues. • Our company has seen an excessive channel stock built up during the covid years that is being reduced. This is impeding top line growth in the recent quarters. We feel this phenomenon is temporary. We have seen closing stock reduction from 65 to 50 days. • We see secondary growth of head ache pain category around 18% in September. We are encouraged by this robust growth and see a overall growth return in second half